Skip to main content

Table 1 Demographic details of 115 patients with oral squamous cell carcinoma

From: Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients

  Frequency (%)   Frequency (%)
Gender   Differentiation  
Male 65 (56.5) Well 32 (27.8)
Female 50 (43.5) Moderate 60 (52.2)
   Moderate-poorly 11 (9.6)
Race   Poorly 12 (10.4)
Caucasian 78 (67.8)   
Indian 10 (8.7) pTNM  
Middle-Eastern 2 (1.7) T1N0M0 58 (50.4)
Oriental 1(0.9) T2N0M0 23 (20.0)
Other Asians 6 (5.2) T1N1M0 6 (5.2)
African 13 (11.3) T2N1M0 6 (5.2)
Caribbean 5 (4.3) T1N2aM0 6 (5.2)
   T2N2aM0 9 (7.8)
Primary site   T1N2bM0 1 (0.9)
Floor of mouth 24 (20.9) T2N2bM0 3 (2.6)
Tongue (lateral) 36 (31.3) T1N2cM0 2 (1.7)
Tongue (dorsal) 13 (11.3) T2N2cM0 1 (0.9)
Tongue (ventral) 5 (4.3)   
Buccal mucosa 11 (9.6) Invasive front (IF)  
Hard palate 3 (2.6) Cohesive 82 (71.3)
Upper alveolus 6 (5.2) Non-cohesive 33 (28.7)
Lower alveolus 6 (5.2) Dys. At Margin 53 (46.1)
Retromolar area 3 (2.6) Lymphvascular Invasion 28 (24.3)
Tuberosity 1 (0.9) Nerve Invasion 12 (10.4)
Upper lip 1 (0.9) B/C Invasion 5 (4.3)
Lower lip 5 (4.3) SD present 72 (62.6)
Neck Lump* 1 (0.9) Tumour clearance 107 (93.0)
cTNM   Recurrence 43 (37.4)
T1N0M0 62 (53.9)   
T2N0M0 24 (20.9) Recurrence Rx  
T1N1M0 3 (2.6) Surgery 2 (1.7)
T2N1M0 5 (4.3) Surgery + radio 13 (11.3)
T1N2aM0 5 (4.3) Radio + chemo 5 (4.3)
T2N2aM0 9 (7.8) PDT 2 (1.7)
T1N2bM0 1 (0.9) Radiotherapy 21 (18.3)
T2N2bM0 3 (2.6)   
T1N2cM0 3 (2.6) 3 year survival 86 (74.8)
Primary Rx   5 year survival 83 (72.2)
Surgery 90 (78.3)   
Surgery + radio 22 (19.1)   
Surgery + radio + chemo 3 (2.6)   
Age at 1st OSCC   Depth of Invasion (mm)  
Minimum 20 Minimum 1.0
Maximum 96 Maximum 18.0
Mean 61.70 Mean 5.657
  1. *Primary site was identified before surgery and staged by cTNM, hence no T0 in the table.